Profil
Stuart Chaffee is an Independent Director at ABG Acquisition Corp.
I.
He was previously the Chief Financial Officer at Praxis Precision Medicines, Inc. in 2020 and the Head of Business Operations at Kymera Therapeutics, Inc. from 2016 to 2017.
Dr. Chaffee holds an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Stuart Chaffee
| Sociétés | Poste | Début |
|---|---|---|
| ABG ACQUISITION CORP. I | Directeur/Membre du Conseil | - |
Anciens postes connus de Stuart Chaffee
| Sociétés | Poste | Fin |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Directeur Financier/CFO | 02/12/2020 |
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2017 |
Formation de Stuart Chaffee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
ABG Acquisition Corp. I
ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
















